The department of radiation oncology at Long Beach Memorial Medical Center in Calif., has installed BSD Medical’s BSD-2000 hyperthermia system for ongoing clinical investigations of the use of deep hyperthermia, delivered using the BSD-2000 in with radiotherapy for the treatment of patients suffering from locally advanced, persistent or recurrent deep tumors of the pelvis under an FDA approved protocol.
The Salt Lake City-based BSD said that brachytherapy provides radiation therapy by inserting radioactive “seeds,” isolating the radiation exposure to tumors and preserving the healthy cells. He is also a leader in the combined use of radiation and hyperthermia therapy in the treatment of superficial cancer, as provided by BSD’s systems.
The company said its BSD hyperthermia system delivers heat energy to tumors in the body. It is used in combination with radiation therapy to enhance treatment effects by making cancer cells more sensitive to radiation.
BSD said that it currently has a pre-market approval submission for marketing approval of the BSD-2000 hyperthermia system under review at the FDA.